期刊文献+

河南省某县HIV感染者耐药性影响因素分析 被引量:12

Study on influencing factors of emergence of HIV drug resistance in one county of Henan province
下载PDF
导出
摘要 目的了解河南省某县抗人类免疫缺陷病毒(HIV)治疗病人耐药毒株产生的影响因素。方法对河南省某县抗HIV治疗病人进行队列研究,采用问卷调查和实验室检测耐药性结合的方法,用寿命表方法计算累积耐药率,用COX回归方法分析耐药性产生的影响因素。结果河南省某县艾滋病患者抗病毒治疗时间为182.5,365,547.5,730d,累积耐药率分别为19.0%,35.8%,41.7%,48.2%。家庭人均月收入高、医生经常主动询问服药后情况和已婚是影响耐药产生的保护性因素,而治疗前有临床症状和3 d内漏服治疗药物是耐药产生的危险因素。结论应加大医疗救助、抗病毒治疗督导与管理、加强病人关怀等方面的力度,努力提高病人服药的依从性,以减缓耐药毒株的产生。 Objective To understand the influencing factors of the emergence of HIV drug resistance in antiretroviraltreated patients infected with HIV/AIDS in Henan, China. Methods Cohort study was performed in the HIV infected patients receiving antiretroviral treatment. Investigation and blood collection for drug resistance detection were conducted to study the emergence and influencing factors of HIV drag resistance. The cumulative rate of drug resistance was calculated by life table and influencing factors by Cox regression. Results The cumulative rates of drug resistance in half a year, one year, one and a half years and two yearn were 19.0 %, 35.8 %, 41.7 %, 48.2 %. Higher average income of every person of the family, high frequency of the doctors asking the states of the patients after treatment and being married were the protecting factors. The risk factors were occured symptoms before therapy and poor adherence based on 3 - day recall. Conclusion Enhanced the salvation and care to the HIV infected patients and strengthening the supervision on the patients undergoing therapy was necessary to enhance the adherence to therapy and reduce the emergence speed of the resistant strains.
出处 《中国公共卫生》 CAS CSCD 北大核心 2007年第7期803-805,共3页 Chinese Journal of Public Health
基金 卫生部艾滋病防治应用性研究项目资助(WA2003-01)
关键词 人类免疫缺陷病毒(HIV) 耐药性 影响因素 前瞻性研究 HIV resistance influencing factors cohort study
  • 相关文献

参考文献17

  • 1中华人民共和国卫生部,联合国艾滋病规划署,世界卫生组织.2005年中国艾滋病疫情与防治工作进展[R].北京:卫生部,2006.
  • 2Montaner JS,Hogg R,Raboud J,et al.Antiretroviral treatment in 1998[J].Lancet,1998,352:1919-1922.
  • 3张福杰.国家艾滋病免费抗病毒治疗手册[M].北京:人民卫生出版社,2005.
  • 4Fabianna Bahia,Celia Pedroso,Eduardo Martins,et al.Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy[J].BJID,2004,8:281-289.
  • 5李珏,李敬云.HIV耐药性研究进展[J].中国艾滋病性病,2004,10(4):309-311. 被引量:10
  • 6Brian Conway,Mark A,Wainberg,et al.Development of drug resistance in patients receiving combinations of zidovudine,didanosine and neviraping[J].AIDS,2001,15(10):1269-1274.
  • 7张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:106
  • 8吴亚松,吴昊.HIV的耐药研究进展[J].国外医学(病毒学分册),2004,11(6):190-192. 被引量:3
  • 9Amsten J,Demas P,Gourevitch M,et al.Adherence and viral load in HIV-infected drug users:comparison of self-report and medication events monitors.7th conference on retroviruses and opportunistic infections[M].San Francisco,CA,2000.
  • 10Salit IE,Sano M,Boggild AK,et al.Travel patterns and risk behaviour of HIV-positive people travelling internationally[J].CMAJ,2005,172:884-888.

二级参考文献76

  • 1Perez-Elias MJ,Lanier R,Munoz V,et al. Phenotypic testing predicts virological response in successive protease inhibitor-based regimens[J]. AIDS, 2000,14:F95-F101.
  • 2Coffin J M. HIV population dynamics in vivo:implications for genetic variation,pathogenesis and therapy[J]. Science,1995,267: 483-489.
  • 3De Gruttola V,Dix L,D'Aquila R,et al. The relation between baseline HIV drug resistance and response to antiretroviral therapy:reanalysis of retrospective and prospective studies using a standardized data analysis plan[J]. Antiviral Ther,2000,5:41-48.
  • 4Palmer S,Shafer RW,Merigan TC. Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development[J]. AIDS, 1999, 13:661-667.
  • 5Robert L. Murphy. New antiretroviral drug in development[J]. AIDS, 2000,14(suppl 3):S227-S234.
  • 6Menendez-Arias,L. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases[J]. Progr Nucleic Acid Res Mol Biol, 2002, 71: 91-147.
  • 7Havlir DV,Richman DD. Viral dynamics of HIV:implications for drug development and therapeutic strategies[J]. Ann Intern Med, 1996, 124:984-994.
  • 8Miller V,Ait-Khaled M,Stone C,et al. HIV-1 reverse transcriptase(RT)genotype and susceptibility to PT inhibitors during abacavir monotherapy and combination therapy[J]. AIDS, 2000, 14:163-171.
  • 9Petropoulos CJ,Parkin NT,Limoli KL,et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 [J]. Antimicrob Agents Chemotherap, 2000, 44:92928.
  • 10Montaner JS,Hogg R,Raboud J,et al. Antiretroviral treatment in 1998[J]. Lancet, 1998,352:1919-1922.

共引文献118

同被引文献104

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部